Hi, Bab, it's Matt here and welcome back to the podcast.

Today is another one of those episodes of Hot Off the Press.

This is a really interesting study.

It looked at the interaction between sleep, a new class of sleeping pills,

your metabolism and as a consequence, weight management.

And more specifically, we'll be looking at a class of insomnia drugs known as the DORAs,

that is spelled capital D-O-R-A small S.

And it stands for dual-orexin receptor antagonists.

Don't worry, I'll unpack it and I'll explain it.

But it is a class of drugs.

And currently in the United States, at least, there are three FDA-approved Dora's drugs, and we will speak about one of them today.

And specifically, we won't just talk about what the drug is and how it works for insomnia.

We'll also speak about whether or not it may help you burn fat while you sleep and yet still preserve some muscle.

Right from the get-go, I think it's crucial to approach this topic with caution.

The potential benefit of these Dora's drugs, and specifically the one that we'll speak about today, which is called Belsomra, or its pharmacological name, is called suvo-rexant. But the potential for these drugs,

specifically Belsomra, or suvorexent, for fat-burning during sleep, these are based on just some preliminary research that we'll

discuss. And as with all first studies, it is a fantastic potential outlet for further research,

but it is just a small study and I want to couch that right up front. Before we dive into the actual study itself

and the findings, let's understand what these Dora's drugs do. And I said that the term describes

what we call the dualorexin receptor antagonists or the antagonist drugs. What is orexin? Well, orexin, which is also known by a

different name called hypochretin, and by the way, they are interchangeable. It's the same chemical.

And more specifically, it's what we call a neuropeptide. And it's produced

...